Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Hurwitz

Showing results (11-20 of 182) with videos related to

Pageof 19
Sort By:
Biochimica Et Biophysica Acta|April 25, 1977
An analysis of molecular interactions involved in the assembly of tropomyosin tactoidsF I Hurwitz, A G Walton
The Oncologist|June 5, 2004
Targeted therapy of colorectal cancer: clinical experience with bevacizumabNishan H Fernando, Herbert I Hurwitz
International Journal of Peptide and Protein Research|January 1, 1976
Conformational analysis of a chain reversal in alpha-chymotrypsinF I Hurwitz, A J Hopfinger
Expert Opinion on Biological Therapy|June 28, 2013
Targeted inhibition of VEGF receptor 2: an update on ramucirumabJeffrey Melson Clarke, Herbert I Hurwitz
Journal of Studies on Alcohol|September 1, 1977
Non-help-seeking wives of employed alcoholics. A multilevel interpersonal profileJ I Hurwitz, D K Daya
Nature Reviews. Clinical Oncology|November 15, 2012
Ziv-aflibercept: binding to more than VEGF-A--does more matter?Jeffrey M Clarke, Herbert I Hurwitz
Obstetrics and Gynecology Clinics of North America|March 1, 1994
Primary chemotherapy in epithelial ovarian cancerH I Hurwitz, W P McGuire
Biochemical and Biophysical Research Communications|February 9, 1976
Structural analysis of tropomyosin tactoidsF I Hurwitz, A G Walton
Seminars in Oncology|June 13, 2003
Inhibition of vascular endothelial growth factor in the treatment of colorectal cancerNishan H Fernando, Herbert I Hurwitz
Seminars in Oncology|February 24, 2005
Targeting vascular endothelial growth factor and angiogenesis for the treatment of colorectal cancerTimothy S Collins, Herbert I Hurwitz
Pageof 19

Showing results (11-20 of 182) with videos related to

Sort By:
Pageof 19
Biochimica Et Biophysica Acta|April 25, 1977
An analysis of molecular interactions involved in the assembly of tropomyosin tactoidsF I Hurwitz, A G Walton
The Oncologist|June 5, 2004
Targeted therapy of colorectal cancer: clinical experience with bevacizumabNishan H Fernando, Herbert I Hurwitz
International Journal of Peptide and Protein Research|January 1, 1976
Conformational analysis of a chain reversal in alpha-chymotrypsinF I Hurwitz, A J Hopfinger
Expert Opinion on Biological Therapy|June 28, 2013
Targeted inhibition of VEGF receptor 2: an update on ramucirumabJeffrey Melson Clarke, Herbert I Hurwitz
Journal of Studies on Alcohol|September 1, 1977
Non-help-seeking wives of employed alcoholics. A multilevel interpersonal profileJ I Hurwitz, D K Daya
Nature Reviews. Clinical Oncology|November 15, 2012
Ziv-aflibercept: binding to more than VEGF-A--does more matter?Jeffrey M Clarke, Herbert I Hurwitz
Obstetrics and Gynecology Clinics of North America|March 1, 1994
Primary chemotherapy in epithelial ovarian cancerH I Hurwitz, W P McGuire
Biochemical and Biophysical Research Communications|February 9, 1976
Structural analysis of tropomyosin tactoidsF I Hurwitz, A G Walton
Seminars in Oncology|June 13, 2003
Inhibition of vascular endothelial growth factor in the treatment of colorectal cancerNishan H Fernando, Herbert I Hurwitz
Seminars in Oncology|February 24, 2005
Targeting vascular endothelial growth factor and angiogenesis for the treatment of colorectal cancerTimothy S Collins, Herbert I Hurwitz
Pageof 19